Asset Details
Do you wish to reserve the book?
Muscle Function and Cognitive Performance in Autosomal Dominant AlzheimerDisease Insights from the PSEN1‐E280A Colombian Kindred
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Muscle Function and Cognitive Performance in Autosomal Dominant AlzheimerDisease Insights from the PSEN1‐E280A Colombian Kindred
Do you wish to request the book?
Muscle Function and Cognitive Performance in Autosomal Dominant AlzheimerDisease Insights from the PSEN1‐E280A Colombian Kindred
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Muscle Function and Cognitive Performance in Autosomal Dominant AlzheimerDisease Insights from the PSEN1‐E280A Colombian Kindred
2025
Overview
Background Carriers of the PSEN1‐E280A variant, the largest known autosomal dominant Alzheimer's disease (ADAD) cohort, typically experience mild cognitive impairment by age 44 and dementia by 49. Emerging evidence suggests gait speed (GS) may be an early marker of cognitive decline. While past research focused on older adults, recent studies explore muscle decline in younger individuals. This study examines the relationship between GS and cognition within the Colombian PSEN1‐E280A cohort. Method The study included 134 individuals from families affected by early‐onset ADAD with the PSEN1 gene variant. Among them, 66 were carriers (including 5 with mild cognitive impairment and 5 with dementia), while 68 were non‐carriers. The participants had a mean age of 32 years (SD = 8.72), with 49.3% being male. Cognitively‐unimpaired status was defined by Functional Assessment Staging (FAST) scores <2. Muscle function was assessed through single‐task GS, and its association with cognitive function and functional stages was analyzed. Univariate and multivariate analyses were conducted to explore these relationships. Result The carrier group had a mean GS of 1.56 m/s, compared to 1.64 m/s for the non‐carrier group (p = 0.307). On the MMSE, all carriers scored an average of 26.55 (SD = 4.56), while non‐carriers scored 28.81 (SD = 1.24), a statistically significant difference (p < 0.001). GS was significantly slower in the cognitively‐impaired group compared to cognitively‐unimpaired group (1.37 m/s vs. 1.63 m/s; p = 0.042). Pearson correlation analysis revealed a weak positive correlation between GS and MMSE (r = 0.18; p = 0.041), with this effect being more pronounced in the impaired group. Conclusion Our findings show that single‐task GS does not differentiate young individuals with ADAD due to PSEN1‐E280A but is significantly associated with global cognitive function, particularly in cognitively‐impaired individuals. This suggests that gait impairments emerge as cognitive decline progresses, consistent with findings in sporadic Alzheimer's disease, where motor dysfunction often appears in early symptomatic stages. These results reinforce the link between motor decline and cognitive impairment. Further research is needed to explore the interplay between cognitive and physical performance in this population.
